Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19

BACKGROUND: Administration of Hydroxychloroquine and Azithromycin in patients with coronavirus disease 2019 (COVID-19) prolongs QTc corrected interval (QTc). The effect and safety of Lopinavir/Ritonavir in combination with these therapies have seldom been studied. OBJECTIVES: Our aim was to evaluate...

詳細記述

保存先:
書誌詳細
出版年:J Electrocardiol
主要な著者: Echarte-Morales, Julio, Minguito-Carazo, Carlos, del Castillo-García, Samuel, Borrego-Rodríguez, Javier, Rodríguez-Santamarta, Miguel, Sánchez-Muñoz, Enrique, Bergel-García, Rubén, González-Maniega, Clea, Prieto-González, Silvia, Menéndez-Suarez, Paula, Tundidor-Sanz, Elena, Benito-González, Tomás, Fernández-Vázquez, Felipe
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier Inc. 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7698653/
https://ncbi.nlm.nih.gov/pubmed/33307378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jelectrocard.2020.11.012
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料